Indication
Idiopathic macular telangiectasia type 2
Idiopathic macular telangiectasia type 2 is a chronic, bilateral, slowly progressive neurodegenerative disorder of the central retina that predominantly manifests in middle-aged and older adults. Read more about Idiopathic macular telangiectasia type 2
1 drugs 1 manufacturers
Drugs that treat it
Common Idiopathic macular telangiectasia type 2 therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonIdiopathic macular telangiectasia type 2 is a chronic, bilateral, slowly progressive neurodegenerative disorder of the central retina that predominantly manifests in middle-aged and older adults.
The pathophysiology involves the degeneration of retinal Müller glial cells and photoreceptors, accompanied by secondary vascular remodeling in the juxtafoveal region.
Characteristic clinical features include loss of retinal transparency, depletion of macular pigment, telangiectatic and ectatic capillary alterations that often exhibit late hyperfluorescent leakage, crystalline deposits, and cavitary changes with ellipsoid zone disruption on optical coherence tomography.
As the disease advances, patients experience progressive loss of central visual acuity, paracentral scotomas, and complications such as retinal pigment epithelium hyperplasia or subretinal neovascularization.
- retinalphysician.com
Idiopathic macular telangiectasia type 2 is a chronic, bilateral, slowly progressive neurodegenerative disorder of the central retina that predominantly manifests in middle-aged and older adults The pathophysiology involves the degeneration of retinal Müller glial cells and photoreceptors, accompanied by secondary vascular remodeling in the juxtafoveal region Characteristic clinical features include loss of retinal transparency, depletion of macular pigment, telangiectatic and ectatic capillary ...
- nih.gov
Idiopathic macular telangiectasia type 2 is a chronic, bilateral, slowly progressive neurodegenerative disorder of the central retina that predominantly manifests in middle-aged and older adults Characteristic clinical features include loss of retinal transparency, depletion of macular pigment, telangiectatic and ectatic capillary alterations that often exhibit late hyperfluorescent leakage, crystalline deposits, and cavitary changes with ellipsoid zone disruption on optical coherence tomography...
- nih.gov
Idiopathic macular telangiectasia type 2 is a chronic, bilateral, slowly progressive neurodegenerative disorder of the central retina that predominantly manifests in middle-aged and older adults As the disease advances, patients experience progressive loss of central visual acuity, paracentral scotomas, and complications such as retinal pigment epithelium hyperplasia or subretinal neovascularization
- healio.com
The pathophysiology involves the degeneration of retinal Müller glial cells and photoreceptors, accompanied by secondary vascular remodeling in the juxtafoveal region
- retinact.com
The pathophysiology involves the degeneration of retinal Müller glial cells and photoreceptors, accompanied by secondary vascular remodeling in the juxtafoveal region
- retinalphysician.com
Characteristic clinical features include loss of retinal transparency, depletion of macular pigment, telangiectatic and ectatic capillary alterations that often exhibit late hyperfluorescent leakage, crystalline deposits, and cavitary changes with ellipsoid zone disruption on optical coherence tomography As the disease advances, patients experience progressive loss of central visual acuity, paracentral scotomas, and complications such as retinal pigment epithelium hyperplasia or subretinal neova...
Personalize your experience
Follow Idiopathic macular telangiectasia type 2 and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.